Related Experiment Video
Updated: Jan 31, 2026

RNAi Screening to Identify Postembryonic Phenotypes in C. elegans
Published on: February 13, 2012
A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest
Katharina Deiss1, Nicola Lockwood1, Michael Howell2
1Protein Phosphorylation Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Abstract:
The Topo2a-dependent arrest is associated with faithful segregation of sister chromatids and has been identified as dysfunctional in numerous tumour cell lines. This genome-protecting pathway is poorly understood and its characterization is of significant interest, potentially offering interventional opportunities in relation to synthetic lethal behaviours in arrest-defective tumours. Using the catalytic Topo2a inhibitor ICRF193, we have performed a genome-wide siRNA screen in arrest-competent, non-transformed cells, to identify genes essential for this arrest mechanism. In addition, we have counter-screened several DNA-damaging agents and demonstrate that the Topo2a-dependent arrest is genetically distinct from DNA damage checkpoints. We identify the components of the SMC5/6 complex, including the activity of the E3 SUMO ligase NSE2, as non-redundant players that control the timing of the Topo2a-dependent arrest in G2. We have independently verified the NSE2 requirement in fibroblasts from patients with germline mutations that cause severely reduced levels of NSE2. Through imaging Topo2a-dependent G2 arrested cells, an increased interaction between Topo2a and NSE2 is observed at PML bodies, which are known SUMOylation hotspots. We demonstrate that Topo2a is SUMOylated in an ICRF193-dependent manner by NSE2 at a novel non-canonical site (K1520) and that K1520 sumoylation is required for chromosome segregation but not the G2 arrest.
Insights
The SMC5/6 complex, particularly NSE2, is crucial for the Topoisomerase 2-alpha (Topo2a)-dependent G2 arrest, a vital genome-protection pathway. This discovery offers new insights into cancer interventions for arrest-defective tumors.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- The Topoisomerase 2-alpha (Topo2a)-dependent cell cycle arrest is critical for faithful sister chromatid segregation and is often dysfunctional in cancer cells.
- Understanding this genome-protection pathway is essential for developing targeted cancer therapies, particularly exploiting synthetic lethality in tumors with defective arrest mechanisms.
Purpose of the Study:
- To identify genes essential for the Topo2a-dependent G2 arrest using a genome-wide siRNA screen.
- To investigate the genetic relationship between the Topo2a-dependent arrest and DNA damage checkpoints.
- To elucidate the role of the SMC5/6 complex and NSE2 in regulating this arrest.
Main Methods:
- Genome-wide siRNA screen using the Topo2a inhibitor ICRF193 in arrest-competent cells.
- Counter-screening with various DNA-damaging agents.
- Verification of findings in patient-derived fibroblasts with NSE2 mutations.
- Imaging studies to observe protein interactions and SUMOylation.
Main Results:
- The Topo2a-dependent G2 arrest is genetically distinct from DNA damage checkpoints.
- Components of the SMC5/6 complex, including the E3 SUMO ligase NSE2, are essential for controlling the timing of the Topo2a-dependent G2 arrest.
- NSE2's role was confirmed in patient fibroblasts with reduced NSE2 levels.
- Increased interaction between Topo2a and NSE2 was observed at PML bodies during Topo2a-dependent G2 arrest.
- Topo2a is SUMOylated by NSE2 at K1520 in an ICRF193-dependent manner, which is required for chromosome segregation but not the G2 arrest itself.
Conclusions:
- The SMC5/6 complex, particularly NSE2-mediated SUMOylation of Topo2a at K1520, plays a critical, non-redundant role in regulating the Topo2a-dependent G2 arrest and subsequent chromosome segregation.
- These findings highlight potential therapeutic targets for cancers with defects in this crucial genome-protection pathway.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Positive Regulator Molecules
Genomics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Negative Regulator Molecules
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

